This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Calgary directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $757,352
Targeting a unique glutamine dependence in brain tumour stem cells: A novel therapeutic option for GBM
CIHR · 2016 · Principal investigator
Targeting a unique glutamine dependence in brain tumour stem cells: A novel therapeutic option for GBM
Principal investigators: Weiss, Samuel; Luchman, Hema A
Keywords: Brain Tumour Stem Cells; Cancer Stem Cells; Experimental Therapeutics; Glioblastoma; Glutamine Dependence; Glycolysis; Metabolism; Stat3 Signalling
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.